HS-10517
/ Jiangsu Hansoh Pharma, GHDDI
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 22, 2023
Study of HS-10517 in Chinese Adult Participants
(clinicaltrials.gov)
- P1/2 | N=340 | Recruiting | Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
New P1/2 trial • Infectious Disease • Novel Coronavirus Disease
1 to 1
Of
1
Go to page
1